3,4-dichloroisocoumarin has been researched along with nelfinavir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, WA; Fousek, K; Guan, M; Guo, S; Jiang, C; Shih, CC; Synold, T; Xi, B | 1 |
1 other study(ies) available for 3,4-dichloroisocoumarin and nelfinavir
Article | Year |
---|---|
Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
Topics: Activating Transcription Factor 6; Animals; Antineoplastic Agents; Apoptosis; Caspase 6; Caspase 9; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Coumarins; Endoplasmic Reticulum; Enzyme Activation; Fatty Acid Synthase, Type I; Female; Humans; Isocoumarins; Liposarcoma; Metalloendopeptidases; Mice; Mice, SCID; Nelfinavir; Neoplasm Transplantation; Phenanthrolines; Proprotein Convertases; Protease Inhibitors; Protein Transport; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic; Transplantation, Heterologous; Tumor Burden | 2011 |